Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02559505 · ClinicalTrials.gov registry record · NA
Influenza Immunity in Children
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT02559505 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 134 participants.
The verdict
NCT02559505, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
This study evaluates how different methods of early exposure to influenza (natural infection, live attenuated influenza vaccination, inactivated influenza vaccination) initially stimulate immunity and poise the immune system to respond to a future challenge with the inactivated influenza vaccine.
Interventions
- BIOLOGICAL Seasonal IIV 0.25 mL dose
- OTHER Natural influenza infection
- BIOLOGICAL Seasonal IIV 0.5 mL dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2015-10 |
| Est. Completion | 2020-07-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02559505
The ClinicalTrials.gov registry entry for NCT02559505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Seasonal IIV 0.25 mL dose is the first listed.
NCT02559505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02559505 about?
NCT02559505 is a clinical study titled "Influenza Immunity in Children". This study evaluates how different methods of early exposure to influenza (natural infection, live attenuated influenza vaccination, inactivated influenza vaccination) initially stimulate immunity and poise the immune system to respond to a future challenge with the inactivated influenza vaccine.
What is the current status of trial NCT02559505?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2015-10. Estimated completion is 2020-07-03.
What interventions are being tested in trial NCT02559505?
The interventions under investigation include: Seasonal IIV 0.25 mL dose (BIOLOGICAL), Natural influenza infection (OTHER), Seasonal IIV 0.5 mL dose (BIOLOGICAL).
Who is sponsoring clinical trial NCT02559505?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.